Ocular Therapeutix™ Announces 12-Month Topline Data from
OTX-TKI maintained vision and CSFT comparable to aflibercept every eight weeks, with 89% reduction in treatment burden over a 12-month period OTX-TKI...
Source: globenewswire.com
Month Topline Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Month Topline Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.